© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
ClearPoint Neuro, Inc. (CLPT) stock surged +8.11%, trading at $10.00 on NASDAQ, up from the previous close of $9.25. The stock opened at $9.00, fluctuating between $8.95 and $10.58 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 06, 2026 | 9.00 | 10.58 | 8.91 | 10.00 | 1.73M |
| Mar 03, 2026 | 9.50 | 9.55 | 8.83 | 8.84 | 1.92M |
| Mar 02, 2026 | 9.90 | 10.49 | 9.05 | 9.80 | 4.03M |
| Feb 27, 2026 | 13.91 | 14.10 | 12.52 | 12.57 | 1.09M |
| Feb 26, 2026 | 14.82 | 15.00 | 12.90 | 14.43 | 1.42M |
| Feb 25, 2026 | 14.65 | 15.26 | 14.49 | 15.16 | 567.14K |
| Feb 24, 2026 | 14.70 | 15.09 | 14.23 | 14.55 | 409.75K |
| Feb 23, 2026 | 14.12 | 14.91 | 13.71 | 14.76 | 732.38K |
| Feb 20, 2026 | 14.33 | 14.53 | 14.05 | 14.15 | 322.52K |
| Feb 19, 2026 | 14.09 | 14.38 | 13.80 | 14.35 | 283.05K |
| Feb 18, 2026 | 13.67 | 14.53 | 13.60 | 14.19 | 572.44K |
| Feb 17, 2026 | 13.50 | 14.01 | 13.43 | 13.58 | 459.51K |
| Feb 13, 2026 | 13.17 | 14.16 | 13.13 | 13.55 | 636.19K |
| Feb 12, 2026 | 13.33 | 13.62 | 12.55 | 13.04 | 560.68K |
| Feb 11, 2026 | 13.61 | 13.74 | 12.88 | 13.37 | 430.41K |
| Feb 10, 2026 | 14.09 | 14.42 | 13.56 | 13.59 | 459.68K |
| Feb 09, 2026 | 13.49 | 14.15 | 13.12 | 14.11 | 424.1K |
| Feb 06, 2026 | 12.70 | 13.60 | 12.70 | 13.46 | 418.78K |
| Feb 05, 2026 | 12.97 | 13.18 | 12.37 | 12.57 | 750.27K |
| Feb 04, 2026 | 13.99 | 14.07 | 12.66 | 13.31 | 874.05K |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
| Employees | 115 |
| Beta | 1.02 |
| Sales or Revenue | $23.96M |
| 5Y Sales Change% | 0.447% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |